ACCUSIGN DOA 3/DOA 3 (BZO/BAR/PCP), BZO/BAR/PCP, BIOSIGN DOA 3/BZO/BAR/PCP, BIOSIGN BZO/BAR/PCP— 510(k) K961325

Substantially Equivalent

Princeton BioMeditech Corp.

FDA 510(k) clearance K961325 for ACCUSIGN DOA 3/DOA 3 (BZO/BAR/PCP), BZO/BAR/PCP, BIOSIGN DOA 3/BZO/BAR/PCP, BIOSIGN BZO/BAR/PCP, Substantially Equivalent on 1996-06-12. Applicant: Princeton BioMeditech Corp..

Clearance details

Applicant: Princeton BioMeditech Corp.
Product code: Code JXM
Advisory panel: Clinical Toxicology
Date received: 1996-04-08
Decision date: 1996-06-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Monmouth Junction, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.